Atlas Trials

Comparison of Tocilizumab Versus Tocilizumab/Infliximab in Patients With COVID-19-associated Cytokine Storm Syndrome

Clinical trial NCT04734678 · COMPLETED

Trial details

NCT number
NCT04734678
Sponsor
Ain Shams University
Status
COMPLETED
Study type
OBSERVATIONAL
Covid19Cytokine StormCorona Virus Infection
Start date
2020-12-01
Primary completion
2021-06-01
Enrollment
153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.